Akanda

Akanda Accounts Payable

The Accounts Payable of Akanda (AKAN) as of Nov 4, 2026 is 3.31 M USD. In the previous year, Accounts Payable was 2.74 M USD — a change of 20.88% (higher).

Accounts Payable

3.31 MUSD

YoY

20.88%

Last updated:

Accounts Payable of Akanda is 2025 3.31 M USD. Accounts Payable of Akanda was 2024 2.74 M USD. It decreases by 20.88% higher compared to the previous year.

The Akanda Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2020
183,895.00 USD
Jan 1, 2021
680,328.00 USD
Jan 1, 2022
7.14 M USD
Jan 1, 2023
6.01 M USD
Jan 1, 2024
2.74 M USD
Jan 1, 2025
3.31 M USD
The Akanda Accounts Payable history
YEARAccounts PayableYoY
3.31 MUSD+20.88%
2.74 MUSD-54.48%
6.01 MUSD-15.76%
7.14 MUSD+949.47%
680,328.00USD+269.95%
183,895.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Akanda Stock analysis

What does Akanda do? Akanda Corp generates revenue through its cultivation, distribution, and corporate segments. The cultivation segment focuses on producing medical cannabis and biomass, while the distribution segment sells products like those from Holigen, a Portugal-based cultivator, manufacturer, and distributor, and CanMart, a UK-based pharmaceutical importer and distributor supplying pharmacies and clinics. Holigen operates a 20,000 square foot indoor facility near Lisbon for high-THC cannabis cultivation. The company’s supply chain includes Cansativa Group, an European medical cannabis importer and distributor, and Cellen Life Sciences Leva Clinic, a UK-based digital pain clinic. Holigen’s products are distributed through Akanda’s network, targeting medical cannabis patients globally. CanMart serves UK pharmacies and clinics, leveraging its pharmaceutical licensing. Cansativa Group and Cellen Life Sciences Leva Clinic are integral to the seed-to-patient supply chain, connecting cultivation with end users. The company monetizes its portfolio by supplying ethically sourced medical cannabis products to patients worldwide through these established brands. Akanda’s revenue streams are derived from the sale of medical cannabis products via Holigen’s cultivation, CanMart’s distribution, and the supply chain involving Cansativa Group and Cellen Life Sciences Leva Clinic. The cultivation segment produces biomass for distribution, while the distribution segment handles sales to healthcare providers and clinics. The corporate segment supports these operations with strategic oversight. Akanda is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Akanda stock

Accounts Payable of Akanda is 3.31 M USD in 2025.

Accounts Payable of Akanda changed from 2.74 M USD to 3.31 M USD, representing a 20.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Akanda since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Akanda historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Akanda

All Key Metrics — Akanda